These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 181148)

  • 1. The identification and significance of hypoxanthine in dialyzable transfer factor.
    Kirkpatrick CH; Robinson LB; Smith TK
    Cell Immunol; 1976 Jun; 24(2):230-40. PubMed ID: 181148
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of Tx, an active subfraction of human dialyzable transfer factor. I. Identification of the major component in TFg, a precursor of Tx, as hypoxanthine.
    Wilson GB; Welch TM; Knapp DR; Horsmanheimo A; Fudenberg HH
    Clin Immunol Immunopathol; 1977 Nov; 8(3):551-68. PubMed ID: 912950
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of hypoxanthine as the major compoenet of a chromatographic fraction of transfer factor.
    O'Dorisio MS; Neidhart JA; Daniel FB; Balcerzak SP; LoBuglio AF
    Cell Immunol; 1976 May; 23(2):191-202. PubMed ID: 1277303
    [No Abstract]   [Full Text] [Related]  

  • 4. Serial transfer of delayed hypersensitivity with dialyzable transfer factor.
    Kirkpatrick CH; Smith TK
    Cell Immunol; 1976 Dec; 27(2):323-7. PubMed ID: 795550
    [No Abstract]   [Full Text] [Related]  

  • 5. Transfer factor: delayed hypersensitivity to Schistosoma mansoni and tuberculin in Macaca mulatta.
    Maddison SE; Hicklin MD; Conway BP; Kagan IG
    Science; 1972 Nov; 178(4062):757-9. PubMed ID: 4628344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfer factor: specific and nonspecific effects and chemical characteristics of dialyzable leukocyte lysates (DLL). Part III. Biochemical characterization. (third of three parts).
    Ablin RJ
    Allergol Immunopathol (Madr); 1980; 8(3):203-12. PubMed ID: 7405767
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical analysis of dialyzable leukocyte extracts.
    Gottlieb AA; Saito K; Sutcliffe S; Foster LA; Tamaki N; Maziarz G; Sutherland C; Brennessel B
    J Reticuloendothel Soc; 1977 Jun; 21(6):403-16. PubMed ID: 886545
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotactic activity in dialyzable transfer factor.
    Gallin JI; Kirkpatrick CH
    Proc Natl Acad Sci U S A; 1974 Feb; 71(2):498-502. PubMed ID: 4205594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatographic determination of hypoxanthine and xanthine in biological fluids.
    Boulieu R; Bory C; Baltassat P; Gonnet C
    J Chromatogr; 1982 Dec; 233():131-40. PubMed ID: 6897651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the chemical composition and biological properties of transfer factor.
    Krohn K; Uotila A; Väisänen J; Gröhn P
    Z Immunitatsforsch Immunobiol; 1977 Dec; 153(5):395-411. PubMed ID: 602344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative studies on dialyzable leukocyte extracts containing transfer factor--a review.
    Klesius PH; Fudenberg HH; Smith CL
    Comp Immunol Microbiol Infect Dis; 1980; 3(3):247-60. PubMed ID: 6162606
    [No Abstract]   [Full Text] [Related]  

  • 12. Simultaneous assay of hypoxanthine, xanthine and allopurinol by high-performance liquid chromatography and activation of immobilized xanthine oxidase as an enzyme reactor.
    Kito M; Tawa R; Takeshima S; Hirose S
    Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2459-62. PubMed ID: 2605692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of dialyzable products from human leukocyte extracts on cutaneous delayed-hypersensitivity response.
    Gottlieb AA; Maziarz GA; Tamaki N; Sutcliffe SB
    J Immunol; 1980 Feb; 124(2):885-92. PubMed ID: 7356716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorometric determination of hypoxanthine and xanthine in biological fluids by high-performance liquid chromatography using enzyme reactors.
    Kito M; Tawa R; Takeshima S; Hirose S
    J Chromatogr; 1983 Nov; 278(1):35-42. PubMed ID: 6689328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mass-spectrometirc identification of hypoxanthine and xanthine ('oxypurines') in skeletal musce from two patients with congenital xanthine oxidase deficiency (xanthinuria).
    Prker R; Snedden W; Watts RW
    Biochem J; 1969 Oct; 115(1):103-8. PubMed ID: 5350038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on the mechanisms of tuberculin hypersensitivity. II. Non-dialyzable transfer factor (author's transl)].
    Oyamaguchi A
    Kekkaku; 1982 Apr; 57(4):225-32. PubMed ID: 7109421
    [No Abstract]   [Full Text] [Related]  

  • 17. Dialyzable transfer factor.
    Maddison SE
    South Med J; 1975 Dec; 68(12):1545-51. PubMed ID: 812183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated immunity: correlation of mixed-leucocyte-macrophage migration inhibition with delayed-type hypersensitivity after immunization and donor-specific transfer of cell migration inhibition by dialyzable leucocyte extract.
    Mazaheri R; Hamblin AS; Zuckerman AJ
    Cell Immunol; 1983 Nov; 82(1):147-62. PubMed ID: 6196129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of monocyte cGMP by leukocyte dialysates. An antigen-independent property of dialyzable transfer factor.
    Sandler JA; Smith TK; Manganiello VC; Kirkpatrick CH
    J Clin Invest; 1975 Nov; 56(5):1271-9. PubMed ID: 171284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer factor: specific and nonspecific effects and chemical characteristics of dialyzable leukocyte lysates (DLL). Part I. Introduction. (first of three parts).
    Ablin RJ
    Allergol Immunopathol (Madr); 1980; 8(1):53-60. PubMed ID: 6996464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.